Mizuho Securities USA’s Orion Biotech Opportunities Corp. Class A Ordinary Share ORIA Stock Holding History

Mizuho Securities USA’s Portfolio ORIA Stock Details ORIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-100,000	Closed	-$1.01M	–	241
2023 Q1	$1.01M	Buy	+100,000	New	+$1.02M	0.06%	137

Mizuho Securities USA's ORIA Position: Q2 2023 in Review

Mizuho Securities USA sold out of Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) in Q2 2023, closing a stake of 100,000 shares — an estimated $1.01M sold.

Mizuho Securities USA first reported a position in ORIA in Q1 2023 and held it in 1 quarter. The position peaked at $1.01M in Q1 2023. 0 funds tracked by Wall St. Rank hold ORIA as of Q2 2023.

Mizuho Securities USA reported no remaining Orion Biotech Opportunities Corp. Class A Ordinary Share position as of Q2 2023 after selling out during the quarter.
Mizuho Securities USA sold 100,000 Orion Biotech Opportunities Corp. Class A Ordinary Share shares in Q2 2023, an estimated $1.01M.
Mizuho Securities USA first reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share in Q1 2023 and held it in 1 quarter.
Mizuho Securities USA's Orion Biotech Opportunities Corp. Class A Ordinary Share position peaked at $1.01M in Q1 2023.
0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Class A Ordinary Share as of Q2 2023.

Based on Mizuho Securities USA's 13F filing for Q2 2023, filed 9 Aug 2023.